Landry Benjamin 4

4 · Health Catalyst, Inc. · Filed Feb 27, 2026

AI-generated summary of this filing

Updated Feb 27, 2026

Health Catalyst (HCAT) GC Landry Benjamin Receives Awards, Sells Shares

What Happened

Landry Benjamin, General Counsel of Health Catalyst, was granted a total of 305,473 contingent equity awards on Feb 25, 2026: 289,000 restricted stock units (RSUs) and 16,473 performance-based restricted stock units (PRSUs). These awards were granted at $0.00 per share (they are contingent rights to receive common stock).
On Feb 26, 2026, 6,317 shares were disposed of at $1.75 per share (totaling $11,041). That sale was a mandated "sell to cover" to satisfy tax withholding obligations and not a discretionary open-market sale.

Key Details

Transaction dates: Awards recorded 2026-02-25; sell-to-cover occurred 2026-02-26. Form 4 filed 2026-02-27 (timely).
Award amounts: 289,000 RSUs (F1) and 16,473 PRSUs (F2) — total 305,473 contingent units.
Sale details (tax withholding): 6,317 shares sold at $1.75 each for $11,041 (F3). This sale was to cover tax withholding tied to RSU vesting.
Vesting: RSUs vest in 12 equal quarterly installments beginning March 1, 2026 (per F1). PRSUs are performance-contingent based on FY2025 results (per F2).
Shares owned after transaction: Not specified in this filing.

Context

RSUs and PRSUs are awards that convert to shares only if vesting and/or performance conditions are met; they are not the same as an open-market purchase (not necessarily a bullish signal).
The 6,317-share disposal was a routine sell-to-cover for taxes mandated by the company’s equity plan, not an independent sale decision by the insider.
Filing appears timely (reported within the typical two-business-day window).

Form 4

Period: 2026-02-25

General Counsel

Transactions

Footnotes (3)

[F1]Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will vest in 12 equal quarterly installments beginning on March 1st 2026.
[F2]Represents an award of 16,473 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.
[F3]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Signature

/s/ Benjamin Landry|2026-02-27

1 file